| Literature DB >> 33838737 |
Margaret Pinder1, John Bradley2, Musa Jawara3, Muna Affara4, Lesong Conteh5, Simon Correa3, David Jeffries3, Caroline Jones6, Balla Kandeh7, Jakob Knudsen8, Yekini Olatunji3, Elisa Sicuri9, Umberto D'Alessandro10, Steve W Lindsay11.
Abstract
BACKGROUND: In malaria-endemic areas, residents of modern houses have less malaria than those living in traditional houses. We aimed to assess whether children in The Gambia received an incremental benefit from improved housing, where current best practice of insecticide-treated nets, indoor residual spraying, seasonal malaria chemoprevention in children younger than 5 years, and prompt treatment against clinical malaria was in place.Entities:
Year: 2021 PMID: 33838737 PMCID: PMC8051018 DOI: 10.1016/S2542-5196(21)00002-4
Source DB: PubMed Journal: Lancet Planet Health ISSN: 2542-5196
Figure 1Trial profile
Figure 2Study houses
Unmodified, thatched-roofed house (A), modified, ventilated screened house with metal roof (B), fixed-louvered front door with mosquito screening behind the door (C), screened back door (D), and ventilated screened window in each gable end (E).
Baseline characteristics of surveyed children*
| Sex | |||
| Female | 47% (179/382) | 49% (188/380) | |
| Male | 53% (203/382) | 51% (192/380) | |
| Age, years | 6 (4–8) | 5 (3–8) | |
| Ethnicity | |||
| Fula | 64% (246/382) | 64% (245/380) | |
| Mandinka | 33% (127/382) | 32% (121/380) | |
| Other | 2% (9/382) | 4% (14/380) | |
| Living on north bank of river | 57% (216/382) | 56% (213/380) | |
| Number of children aged 6 months to 13 years old | 4 (3–6) | 4 (3–5) | |
| Slept under ITN previous night | 54% (205/382) | 51% (192/380) | |
| 5% (19/382) | 2% (9/380) | ||
| Prevalence of mild anaemia, >80–110g/L | 46% (172/377) | 50% (190/376) | |
| Prevalence of moderate anaemia, >50–80 g/L | 7% (27/377) | 7% (25/376) | |
| Prevalence of severe anaemia, ≤50 g/L | <1% (1/377) | 1% (3/376) | |
| Haemoglobin, g/L | 11·0 (10·0–11·8) | 10·8 (9·8–11·7) | |
| Prevalence of enlarged spleen | <1% (1/378) | 0% (0/380) | |
Data are % (n/N) or median (IQR). ITN=insecticide-treated net.
Data was not available for 16 children in the control group and 22 children in the intervention group.
Comparison between groups on incidence of clinical malaria, malaria morbidity, and respiratory infections in the modified intention-to-treat population
| Unmodified houses | Modified houses | ||||
|---|---|---|---|---|---|
| Overall | 0·12 (39/330) | 0·20 (65/324) | 1·68 (1·11–2·55) | 1·75 (1·15–2·65) | 0·0085 |
| 2016 | 0·19 (32/166) | 0·30 (50/165) | 1·57 (0·98–2·52) | 1·65 (1·03–2·66) | 0·039 |
| 2017 | 0·04 (7/164) | 0·09 (15/159) | 2·21 (0·91–5·38) | 2·20 (0·90–5·37) | 0·084 |
| Overall | 0·27 (88/330) | 0·32 (105/324) | 1·21 (0·88–1·65) | 1·26 (0·92–1·71) | 0·14 |
| 2016 | 0·40 (67/166) | 0·44 (73/165) | 1·09 (0·76–1·57) | 1·16 (0·81–1·66) | 0·42 |
| 2017 | 0·13 (21/164) | 0·20 (32/159) | 1·57 (0·89–2·75) | 1·59 (0·90–2·79) | 0·11 |
| Overall | 0·52 (169/325) | 0·54 (173/321) | 1·03 (0·74–1·42) | 0·85 (0·65–1·11) | 0·24 |
| 2016 | 0·78 (127/162) | 0·81 (131/162) | 1·03 (0·73–1·45) | 0·84 (0·63–1·14) | 0·26 |
| 2017 | 0·26 (42/163) | 0·26 (42/159) | 1·03 (0·60–1·77) | 0·88 (0·54–1·44) | 0·61 |
Data are rates (event/child-years) or mean (95% CI). RR=rate ratio.
Number of events per child year.
Adjusted for age, riverbank, month of year, and ethnicity.
Clinical malaria incidence is based on axillary temperature of 37·5°C or more and a parasitaemia of any density.
Malaria morbidity incidence is a positive blood slide or rapid diagnostic test with documented or reported fever or feeling unwell.
Figure 3Time to first clinical malaria episode by study group
Comparison between study groups on measures of malaria transmission from cross-sectional surveys in the modified intention-to-treat population
| Unmodified houses (n=370) | Modified houses (n=370) | OR (95% CI) | RR (95% CI) | p value | Unmodified houses (n=361) | Modified houses (n=365) | OR (95% CI) | RR (95% CI) | p value | Unmodified houses (n=354) | Modified houses (n=348) | OR (95% CI) | RR (95% CI) | p value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2% (8/370) | 2% (7/370) | 0·87 (0·31 to 2·43) | .. | p=0·81 | 1% (5/361) | 1% (2/365) | 0·39 (0·08 to 2·04) | .. | p=0·27 | 1% (3/354) | 1% (2/348) | 0·68 (0·11 to 4·07) | .. | 0·67 | |
| Prevalence of mild anaemia, >80 to 110 g/L | 31% (113/368) | 37% (136/370) | 1·31 (0·97 to 1·78) | .. | p=0·083 | 37% (135/361) | 37% (132/364) | 0·95 (0·70 to 1·29) | .. | p=0·75 | 31% (108/354) | 27% (97/348) | 0·88 (0·64 to 1·22) | .. | 0·44 |
| Prevalence of moderate anaemia (>50 to 80 g/L) | 5% (20/368) | 5% (17/370) | 0·84 (0·43 to 1·63) | .. | p=0·60 | 2% (7/361) | 4% (13/364) | 1·87 (0·74 to 4·75) | .. | p=0·19 | 1% (5/354) | 2% (7/348) | 1·43 (0·45 to 4·56) | .. | 0·54 |
| Prevalence of severe anaemia ≤50 g/L | <1% (1/368) | 0% (0/370) | .. | .. | .. | <1% (1/361) | <1% (1/364) | 0·99 (0·06 to 15·92) | .. | p=0·99 | 0% (0/354) | 0% (0/348) | .. | .. | .. |
| Mean haemoglobin, g/L | 11·39 | 11·30 | .. | −0·10 (−0·36 to 0·17) | p=0·47 | 11·33 | 11·24 | .. | −0·08 (−0·30 to 0·14) | p=0·47 | 11·85 | 11·85 | .. | 0·01 (−0·23 to 0·25) | 0·96 |
| Prevalence of enlarged spleen | <1% (1/368) | <1% (1/369) | 1·00 (0·06 to 16·00) | .. | p=1·00 | <1% (1/361) | 0% (0/364) | .. | .. | .. | <1% (1/351) | 0% (0/348) | .. | .. | .. |
Data are % (n/N), OR (95% CI), or RR (95% CI). OR=odds ratio. RR=rate ratio.
Survey 1 was done in December, 2016.
Survey 2 was done in June, 2017.
Survey 3 was done in December, 2017.